Clinical Trial: Tirzepatide Titration to Reduce Side Effects in Individuals With Obesity

U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT07574723) titled 'Tirzepatide Titration to Reduce Side Effects in Individuals With Obesity' on April 19.

Brief Summary: The goal of this clinical trial is to determine whether a flexible, symptom-guided titration strategy for tirzepatide can reduce gastrointestinal side effects while maintaining weight-loss effectiveness in adults with obesity without diabetes. The main questions it aims to answer are:

1. Does flexible, symptom-guided titration reduce nausea and vomiting compared with standard per-label titration?

2. Does flexible titration achieve weight loss comparable to standard titration?

Researchers will compare standard per-label titration wi...